8-144522745-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001024678.4(LRRC24):āc.1272G>Cā(p.Met424Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000606 in 1,587,652 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00028 ( 0 hom., cov: 33)
Exomes š: 0.00064 ( 1 hom. )
Consequence
LRRC24
NM_001024678.4 missense
NM_001024678.4 missense
Scores
3
5
11
Clinical Significance
Conservation
PhyloP100: 2.98
Genes affected
LRRC24 (HGNC:28947): (leucine rich repeat containing 24) Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be integral component of membrane. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.17013398).
BS2
High AC in GnomAd4 at 43 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC24 | NM_001024678.4 | c.1272G>C | p.Met424Ile | missense_variant | 5/5 | ENST00000529415.7 | NP_001019849.2 | |
LRRC14 | NM_014665.4 | c.*1267C>G | 3_prime_UTR_variant | 4/4 | ENST00000292524.6 | NP_055480.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC24 | ENST00000529415.7 | c.1272G>C | p.Met424Ile | missense_variant | 5/5 | 1 | NM_001024678.4 | ENSP00000434849 | P2 | |
LRRC14 | ENST00000292524.6 | c.*1267C>G | 3_prime_UTR_variant | 4/4 | 1 | NM_014665.4 | ENSP00000292524 | P1 | ||
LRRC24 | ENST00000533758.1 | c.1263G>C | p.Met421Ile | missense_variant | 5/5 | 5 | ENSP00000435653 | A2 | ||
LRRC14 | ENST00000528528.1 | n.164C>G | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152210Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
43
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000274 AC: 54AN: 197274Hom.: 0 AF XY: 0.000274 AC XY: 30AN XY: 109652
GnomAD3 exomes
AF:
AC:
54
AN:
197274
Hom.:
AF XY:
AC XY:
30
AN XY:
109652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000640 AC: 919AN: 1435330Hom.: 1 Cov.: 32 AF XY: 0.000617 AC XY: 440AN XY: 712568
GnomAD4 exome
AF:
AC:
919
AN:
1435330
Hom.:
Cov.:
32
AF XY:
AC XY:
440
AN XY:
712568
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000282 AC: 43AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74492
GnomAD4 genome
AF:
AC:
43
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
14
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
19
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2023 | The c.1272G>C (p.M424I) alteration is located in exon 5 (coding exon 4) of the LRRC24 gene. This alteration results from a G to C substitution at nucleotide position 1272, causing the methionine (M) at amino acid position 424 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
P;P
Vest4
MutPred
Loss of catalytic residue at M424 (P = 0.0602);.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at